Nothing Special   »   [go: up one dir, main page]

CO6821951A2 - Combinación que comprende umeclidinio y un corticosteroide - Google Patents

Combinación que comprende umeclidinio y un corticosteroide

Info

Publication number
CO6821951A2
CO6821951A2 CO13287946A CO13287946A CO6821951A2 CO 6821951 A2 CO6821951 A2 CO 6821951A2 CO 13287946 A CO13287946 A CO 13287946A CO 13287946 A CO13287946 A CO 13287946A CO 6821951 A2 CO6821951 A2 CO 6821951A2
Authority
CO
Colombia
Prior art keywords
umeclidinium
corticosteroid
combination
Prior art date
Application number
CO13287946A
Other languages
English (en)
Inventor
Glenn Crater
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO6821951A2 publication Critical patent/CO6821951A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CO13287946A 2011-06-08 2013-12-09 Combinación que comprende umeclidinio y un corticosteroide CO6821951A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161494600P 2011-06-08 2011-06-08

Publications (1)

Publication Number Publication Date
CO6821951A2 true CO6821951A2 (es) 2013-12-31

Family

ID=46201674

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13287946A CO6821951A2 (es) 2011-06-08 2013-12-09 Combinación que comprende umeclidinio y un corticosteroide

Country Status (20)

Country Link
US (1) US20140113888A1 (es)
EP (1) EP2717868A1 (es)
JP (1) JP2014516062A (es)
KR (1) KR20140041699A (es)
CN (1) CN103582477A (es)
AU (1) AU2012266541A1 (es)
BR (1) BR112013031572A2 (es)
CA (1) CA2838030A1 (es)
CL (1) CL2013003497A1 (es)
CO (1) CO6821951A2 (es)
CR (1) CR20130643A (es)
DO (1) DOP2013000290A (es)
EA (1) EA201391618A1 (es)
IL (1) IL229633A0 (es)
MA (1) MA35406B1 (es)
MX (1) MX2013014399A (es)
PE (1) PE20141048A1 (es)
PH (1) PH12013502497A1 (es)
SG (1) SG195262A1 (es)
WO (1) WO2012168161A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010097115A1 (en) 2009-02-26 2010-09-02 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
JP5797778B2 (ja) 2011-12-28 2015-10-21 旭化成イーマテリアルズ株式会社 レドックスフロー二次電池及びレドックスフロー二次電池用電解質膜
RU2666963C2 (ru) 2012-04-13 2018-09-13 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Агрегированные частицы
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
EP4252742A3 (en) 2014-05-28 2023-12-27 GlaxoSmithKline Intellectual Property Development Ltd Fluticasone furoate in the treatment of copd
WO2015193631A1 (en) 2014-06-18 2015-12-23 Cipla Limited Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
CN107200734B (zh) * 2016-03-18 2019-12-24 益方生物科技(上海)有限公司 奎宁环衍生物及其制备方法和用途
TR201712424A2 (tr) * 2017-08-21 2019-03-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
US20210353650A1 (en) * 2020-05-18 2021-11-18 Cai Gu Huang Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
KR100321649B1 (ko) 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
IL154148A0 (en) 2000-08-05 2003-07-31 Glaxo Group Ltd 6.alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
SE527191C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av tiotropium och fluticason
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
PE20060826A1 (es) * 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
RU2010108640A (ru) * 2007-09-12 2011-10-20 Глаксо Груп Лимитед (GB) Новая комбинация терапевтических агентов
WO2010097115A1 (en) * 2009-02-26 2010-09-02 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Also Published As

Publication number Publication date
EA201391618A1 (ru) 2014-05-30
NZ618166A (en) 2016-01-29
WO2012168161A1 (en) 2012-12-13
MX2013014399A (es) 2014-03-21
EP2717868A1 (en) 2014-04-16
KR20140041699A (ko) 2014-04-04
DOP2013000290A (es) 2014-03-16
BR112013031572A2 (pt) 2017-03-21
JP2014516062A (ja) 2014-07-07
SG195262A1 (en) 2013-12-30
US20140113888A1 (en) 2014-04-24
CA2838030A1 (en) 2012-12-13
IL229633A0 (en) 2014-01-30
CL2013003497A1 (es) 2014-07-04
PE20141048A1 (es) 2014-09-08
CN103582477A (zh) 2014-02-12
AU2012266541A1 (en) 2014-01-09
PH12013502497A1 (en) 2019-07-17
CR20130643A (es) 2014-02-04
MA35406B1 (fr) 2014-09-01

Similar Documents

Publication Publication Date Title
CO6821951A2 (es) Combinación que comprende umeclidinio y un corticosteroide
NO2018034I1 (no) Testosteron
DE112012000884A5 (de) Durchführung
IL229621A0 (en) Multi-application environment
BR112013032502A2 (pt) propagandas em vizualização
CO6990720A2 (es) Composiciones que comprenden galatos y galamidas
EP2820198A4 (en) MODULAR WALL INTERNAL FUNCTIONAL LINES
ITMI20121896A1 (it) Mems-chippackage e procedimento per fabbricare un mems-chippackage
EP2788947A4 (en) EDITING DESIGNER
EP2754052A4 (en) ORGANIZATION AND REPRESENTATION OF PARTITION IN POOL
BR112013033944A2 (pt) combinação sinérgica
EP2718374A4 (en) CORE CASE MICRO BALLS
ES2579654T8 (es) Aparato mezclador y dispensador
FI20116089L (fi) Järjestely ja laite
CO6811882A2 (es) Un agente sustentante
BR112014010157A2 (pt) adaptação da linguagem usada em um dispositivo
EP2783258A4 (en) TONER AND DEVELOPER
BR112014023854A2 (pt) Método para montar um distalizador e distalizador
CO6990713A2 (es) Preparaciones que comprenden emodépsido amorfo
BRDI7106112S (pt) Configuração aplicada a grill
FI20115409A (fi) Kiinnityselementti
CO6930331A2 (es) Difusor
BR112013015487A2 (pt) composições e métodos relacionados a carotenóides.
FR2991273B1 (fr) Servofrein a depression
CO6940403A2 (es) Un artículo absorbente que tiene una porción discreta

Legal Events

Date Code Title Description
FC Application refused